(Q34436469)

2 August 2017

1 reference

title

Psoriasis. Immunopathology and immunomodulation (English)

1 reference

2 August 2017

Gottlieb AB

1

1 reference

2 August 2017

publication date

1 October 2001

1 reference

2 August 2017

1 reference

2 August 2017

volume

19

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

649-57, viii

1 reference

Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

PUVA therapy decreases HLA-DR+ CDIa+ Langerhans cells and epidermal cell antigen-presenting capacity in human skin, but flow cytometrically-sorted residual HLA-DR+ CDIa+ Langerhans cells exhibit normal alloantigen-presenting function.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

Intraepidermal lymphocytes in psoriatic lesions are activated GMP-17(TIA-1)+CD8+CD3+ CTLs as determined by phenotypic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiat

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

The immunology of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

Help for cytotoxic-T-cell responses is mediated by CD40 signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

Use of cyclosporin in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

Necrotizing vasculitis and exacerbation of psoriasis after granulocyte colony-stimulating factor for small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

PUVA-induced lymphocyte apoptosis: mechanism of action in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

Trimethylpsoralen bath PUVA is a remittive treatment for psoriasis vulgaris. Evidence that epidermal immunocytes are direct therapeutic targets

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

1alpha,25-dihydroxycholecalciferol and cyclosporine suppress induction and promote resolution of psoriasis in human skin grafts transplanted on to SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

Increased expression of adhesion receptors in both lesional and non-lesional psoriatic skin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

Worsening psoriasis after treatment with G-CSF in a patient with small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

Psoriasis induced at the injection site of recombinant interferon gamma. Results of immunohistologic investigations

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

The effect of tacalcitol (1,24(OH)2D3) on cutaneous inflammation, epidermal proliferation and keratinization in psoriasis: a placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

T-lymphocyte dependence of psoriatic pathology in human psoriatic skin grafted to SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

Studies of the effect of cyclosporine in psoriasis in vivo: combined effects on activated T lymphocytes and epidermal regenerative maturation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

Psoriasis as a model for T-cell-mediated disease: immunobiologic and clinical effects of treatment with multiple doses of efalizumab, an anti-CD11a antibody.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

Cellular actions of etretinate in psoriasis: enhanced epidermal differentiation and reduced cell-mediated inflammation are unexpected outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

In situ hybridization for interleukin 2 and interleukin 2 receptor mRNA in T cells activated in the presence or absence of cyclosporin A.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

Lymphokine gene expression in vivo is inhibited by cyclosporin A.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

Lymphokine and nonlymphokine mRNA levels in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

Stimulation of lymphokine release from T lymphoblasts. Requirement for mRNA synthesis and inhibition by cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

Evidence that cyclosporine inhibits cell-mediated immunity primarily at the level of the T lymphocyte rather than the accessory cell

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

The effect of immunosuppressive agents on the induction of nuclear factors that bind to sites on the interleukin 2 promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

Interleukin 2 and Granulocyte-Macrophage Colony-Stimulating Factor Induce a Perivascular Lymphocytic Infiltrate in a Skin Explant Model

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

Differential effects of cyclosporine A on Langerhans cells and regulatory T-cell populations in severe psoriasis: an immunohistochemical and flow cytometric analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

Methotrexate therapy of psoriasis: differential sensitivity of proliferating lymphoid and epithelial cells to the cytotoxic and growth-inhibitory effects of methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

Role of the CD28 receptor in T-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

Cytokines and chemokines in the initiation and regulation of epidermal Langerhans cell mobilization

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

Successful in vivo blockade of CD25 (high-affinity interleukin 2 receptor) on T cells by administration of humanized anti-Tac antibody to patients with psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

Modulation of epidermal differentiation, tissue inflammation, and T-lymphocyte infilitration in psoriatic plaques by topical calcitriol

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

Dermal dendritic cells are important members of the skin immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

Treatment with anti-tumor necrosis factor alpha (TNF-alpha) monoclonal antibody dramatically decreases the clinical activity of psoriasis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

ELAM-1 is an adhesion molecule for skin-homing T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

Adhesion receptors of the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: a possible cellular basis for remittive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

Regulatory properties of LFA-1 α and β chains in human T-lymphocyte activation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

Cutaneous ulcerations and pustular psoriasis flare caused by recombinant interferon beta injections in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

Dermal injection of immunocytes induces psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970306-5

7 January 2021

10.1016/S0733-8635(05)70306-5

Identifiers

DOI

1 reference

2 August 2017

1 reference